✦ LIBER ✦

Physical therapy in Parkinson’s disease: an open long-term rehabilitation trial

✍ Scribed by M.T. Pellecchia; A. Grasso; L.G. Biancardi; M. Squillante; V. Bonavita; P. Barone

Publisher: Springer
Year: 2004
Tongue: English
Weight: 177 KB
Volume: 251
Category: Article
ISSN: 0340-5354
DOI: 10.1007/s00415-004-0379-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Using global statistical tests in long-t

Using global statistical tests in long-term Parkinson's disease clinical trials

✍ Peng Huang; Christopher G. Goetz; Robert F. Woolson; Barbara Tilley; Douglas Ker 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 87 KB

## Abstract Parkinson's disease (PD) impairments are multidimensional, making it difficult to choose a single primary outcome when evaluating treatments to stop or lessen the long‐term decline in PD. We review commonly used multivariate statistical methods for assessing a treatment's global impact,

Risperidone in levodopa-induced psychosi

Risperidone in levodopa-induced psychosis in advanced parkinson's disease: An open-label, long-term study

✍ Giuseppe Meco; Andrea Alessandri; Patrizia Giustini; Vincenzo Bonifati 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 361 KB 👁 1 views

Long-term effects of tacrine in alzheime

Long-term effects of tacrine in alzheimer's disease: An open study

✍ Sarah A. Eagger; Marcus Richards; Professor Raymond Levy 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 407 KB 👁 2 views

## Abstract To study the efficacy and safety of prolonged tacrine administration, we monitored 41 patients meeting NINCDS–ADRDA criteria for probable Alzheimer's disease while taking tacrine on an open basis for a period of up to 192 weeks. Dependent variables were the Abbreviated Mental Test Score

Physical Exercise as an Adjunct Therapy

Physical Exercise as an Adjunct Therapy in Sleep Apnea—An Open Trial

✍ Valentina Giebelhaus; Kingman P. Strohl; Werner Lormes; Manfred Lehmann; Nikolau 📂 Article 📅 2000 🏛 Springer-Verlag 🌐 English ⚖ 99 KB

S-adenosyl-methionine improves depressio

S-adenosyl-methionine improves depression in patients with Parkinson's disease in an open-label clinical trial

✍ Alessandro Di Rocco; John D. Rogers; Richard Brown; Peter Werner; Teodoro Bottig 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 29 KB 👁 2 views

Risperidone in the treatment of dopamine

Risperidone in the treatment of dopamine-induced psychosis in Parkinson's disease: An open pilot trial

✍ Erich Mohr; Tilak Mendis; Kathleen Hildebrand; Peter Paul De Deyn 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 78 KB 👁 2 views

## Purpose: To evaluate the safety and efficacy of risperidone in patients with parkinson's disease (pd) who are experiencing significant dopamine-induced psychosis. ## Patients and methods: Seventeen patients (median age, 72 yrs) participated in this 12-week, open pilot study receiving 0.5 to 3